ChartRow logo
Sign in
BBIO
BridgeBio Pharma Inc.Stock · Health Care · Russell 2000 0.4%
$81.22−$2.62 (-3.13%)as of market close, Aug 13, 2026
☾ After hours:$81.21+0.00%3:59 PM ET
CompareLLYUNHJNJABBVISRGTMO

How BridgeBio Pharma makes money

Period

How does BridgeBio Pharma make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year, recent quarter, or the trailing twelve months. Straight from SEC filings.

BridgeBio Pharma Inc. · FY2025 · year ended 2025-12-31
Revenue$502MNet loss$733M · 146%Cost of revenue$21M · 4%Gross profit$481M · 96%Operating expenses$1.0B · 200%R&D$452M · 90%SG&A$531M · 106%Other opex$21M · 4%Other expense$209M · 42%Product$362M · 72%License & Service$128M · 26%Royalty$11M · 2%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.